Endocan develops products for critical ailments.
Endocan's product lines continue to mature toward critical care for people suffering from life threatening diseases like cancer and HIV. The Company's strategic research collaborations, including our strategic partners, Cannabis Science, Inc. and the medical cannabis dispensaries in legal state jurisdictions, will advance these cannabinoid-based breakthroughs in the rapidly expanding critical care market. Further, while chemotherapy and surgical treatment costs quickly rise into the hundreds of thousands of dollars per patient on an annual basis, safe, natural, and effective cannabinoid-based treatments for the same ailments are projected to cost less than ten thousand dollars per patient per annum.
Diagnoses of certain maladies are rising, and more diseases are constantly added to the medical canon. Many diseases have been classified as epidemics. The people on this planet are in dire need of something new. Endocan has identified 20 critical ailments that cannabinoids can treat and numerous skin afflictions as well. This section covers the 5 Why's and 1 How about these ailments:
Who can get them? What are they? When can a patient contract them? Where in the body do they appear, and what are the symptoms? Why do they show up? And lastly: How can cannabinoids make a difference?
Explore this section for this information, whether you are a patient, have a loved one with an illness, or are merely interested in cannabinoid science.